Olzap 5 mg (Tablet)
Unit Price: ৳ 2.51 (5 x 14: ৳ 175.70)
Strip Price: ৳ 35.14
Medicine Details
Category | Details |
---|---|
Generic | Olanzapine |
Company | Opsonin pharma ltd |
Also available as |
ProductTitle
- Olzap
Categories
- Medicine
- Pharmaceutical
Description
- Olzap is indicated for the acute and maintenance treatment of schizophrenia and related psychoses.
- Olanzapine is an antipsychotic agent with affinities for serotonin 5HT2A/2C, dopamine D2, and other receptors.
- The initial dose is 5-10 mg once daily for schizophrenia and bipolar disorder.
- Olanzapine can be given without regard to meals.
- Olzap may antagonize the effects of levodopa and dopamine agonists.
- Olanzapine is contraindicated in patients with a known hypersensitivity to any ingredient and in patients with known risk for narrow-angle glaucoma.
- Common undesirable effects include somnolence, weight gain, increased appetite, elevated glucose levels, and more.
- Olanzapine should be used cautiously in patients with certain conditions and age groups.
- Therapeutic Class: Atypical neuroleptic drugs.
- Storage Conditions: Keep below 30°C temperature, away from light & moisture. Keep out of the reach of children.
Dimensions
ColorOptions
Functions
- Treatment of Schizophrenia
- Treatment of Related Psychoses
- Treatment of Acute Manic or Mixed Episodes in Bipolar Disorder
- Antipsychotic Agent
- Maintenance Treatment
Materials
TechnicalSpecifications
- Affinities for serotonin 5HT2A/2C, dopamine D2, and other receptors
- Well absorbed after oral administration with peak plasma concentrations within 5 to 8 hours
- Not mutagenic or clastogenic
- Not carcinogenic
DesignElements
UsabilityFeatures
- Can be given without regard to meals
- Dosage may be adjusted based on individual clinical status
- Maximum dosage is 20 mg daily
- Can be administered with other drugs and alcohol with caution
DosageOptions
- Initial dose is 5-10 mg once daily for schizophrenia and bipolar disorder
- Daily dosage may subsequently be adjusted within the range of 5-20 mg daily
- Maximum dose is 20 mg daily
StorageInstructions
- Keep below 30°C temperature
- Away from light & moisture
- Keep out of the reach of children
Interaction
- May antagonize the effects of levodopa and dopamine agonists
- Drugs that induce CYP1A2 or glucoronyl transferase enzymes may increase Olzap clearance
- Inhibitors of CYP1A2 may potentially inhibit Olzap elimination
- Carbamazepine may increase the clearance of Olzap
- Concomitant administration of activated charcoal reduces the oral bioavailability of Olzap by 50-60%
Contraindications
SideEffects
- Somnolence
- Weight gain
- Increased appetite
- Elevated glucose levels
- Elevated triglyceride levels
- Dizziness
- Akathisia
- Parkinson's disease
- Dyskinesia
- Orthostatic hypotension
- Mild and transient anticholinergic effects including constipation and dry mouth
- Asthenia
- Edema
- Photosensitivity reaction
PregnancyLactation
- Should be used in pregnancy only if the potential benefits justify the potential risk to the fetus
- No reports to show teratogenicity
- Patients should not breastfeed if they are taking Olanzapine
PrecautionsWarnings
- Use cautiously in patients with a history of seizures or conditions associated with seizures
- Use cautiously in patients with low leukocyte and/or neutrophil counts
- Use cautiously in patients with certain hepatic, renal impairments, and age groups
- Patients should be cautioned about operating hazardous machinery, including motor vehicles
SpecialPopulations
- Children: Olzap has not been studied in subjects under 18 years of age
- Elderly patients (age 65 and over): Starting dose 5 mg/day
- Patients with hepatic, renal impairment: Starting dose 5 mg/day
Indication
- Acute and maintenance treatment of schizophrenia and related psychoses
Pharmacology
- Affinity for various receptors
- Proposed efficacy in schizophrenia through a combination of dopamine and serotonin type 2 (5HT2) antagonism
- Well absorbed after oral administration, reaching peak plasma concentrations within 5 to 8 hours
PediatricUses
TherapeuticClass
- Atypical neuroleptic drugs